ConductScience.org, home

Library / Trials

A Classroom-based Intervention to Promote Physical Literacy in Children: ALPHYL Study Protocol

NCT05812118, Not applicable, Completed, University of Valencia

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleA Classroom-based Intervention to Promote Physical Literacy in Children: ALPHYL Study ProtocolClinicalTrials.gov
NCT numberNCT05812118ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment285 participants, actualClinicalTrials.gov
Lead sponsorUniversity of ValenciaClinicalTrials.gov
ConditionsPhysical ActivityClinicalTrials.gov
InterventionsPhysical active learningClinicalTrials.gov
First posted2023-04-13ClinicalTrials.gov
Last updated2023-12-06ClinicalTrials.gov

Registered outcomes 27

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange of the actual motor competenceMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionAssessment of the actual motor competence using Canadian Agility Movement Skill Assessment testClinicalTrials.gov
PrimaryChange of the physical activity levelMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionAssessment of the physical activity by accelerometersClinicalTrials.gov
PrimaryChange of the perceived physical literacyMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionAssessment of this variable using Physical Literacy for Children Questionnaire. Minimum and maximum response values are from 1 to 4. Higher scores mean a better outcome.ClinicalTrials.gov
PrimaryChange of the perceived motor competenceMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionAssessment of this variable using Pictorial scale of Perceived Movement Skill Competence. Minimum and maximum response values are from 1 to 4. Higher scores mean a better outcome.ClinicalTrials.gov
PrimaryChange of the self-determined motivation for physical activityMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionAdapted version for children of the Behavioural Regulation Exercise Questionnaire. Minimum and maximum response values are from 1 to 5. Higher scores mean a better outcome.ClinicalTrials.gov
PrimaryChange of the perceived social supportMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionThe Physical Activity Family and Friends Support Scale. Minimum and maximum response values are from 1 to 5. Higher scores mean a better outcome.ClinicalTrials.gov
PrimaryChange of the academic achievementMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionFinal grade scores at schoolClinicalTrials.gov
PrimaryChange of the working memoryMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionDigit Span testClinicalTrials.gov
PrimaryChange of the executive functionMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionStroop testClinicalTrials.gov
SecondaryChange of the active commuting to/from schoolMeasured at baseline, immediately after the intervention and 8-10 weeks after the intervention
Survey adapted from Centers for Disease Control Kids-Walk-to-School programme by investigators of the International Physical Activity and the Environment Network. Participants will indicate the number of days travelling both to and from school by walking, bicycling or skateboarding in an average school week. Total number of active trips per week to and from school will be summed (range = 0-10 trips). Higher scores mean a better outcome.
ClinicalTrials.gov
SecondaryChange of the body Mass IndexMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionThe assessment of height and weight will be use to calculate body mass indexClinicalTrials.gov
SecondaryChange of the cardiorespiratory fitnessMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionAssessment of this fitness component using Progressive Aerobic Cardiovascular Endurance Run testClinicalTrials.gov
SecondaryChange of the physical activity participation (self-reported)Measured at baseline, immediately after the intervention and 8-10 weeks after the interventionPhysical activity will be self-reported using Physical Activity Questionnaire for Children. Minimum and maximum response values are from 1 to 5. Higher scores mean a better outcome.ClinicalTrials.gov
SecondaryChange of the alienation with schoolMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionHealth Behaviour in school-age children questionnaire. Minimum and maximum response values are from 1 to 5. Higher scores mean a better outcome.ClinicalTrials.gov
SecondaryChange of the body image perceptionMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionChildren Body Figure Silhouette evaluation. Minimum and maximum response values are from 1 to 7. Higher scores mean overweight and obese appearance.ClinicalTrials.gov
SecondaryChange of the physical activity intentionMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionFuture intention of physical activity scale. Minimum and maximum response values are from 1 to 5. Higher scores mean a better outcome.ClinicalTrials.gov
SecondaryChange of the physical activity psychological need satisfaction according to the Self-Determination Theory at physical educationMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionBasic psychological needs satisfaction scale within physical education setting. Minimum and maximum response values are from 1 to 5. Higher scores mean a better outcome.ClinicalTrials.gov
SecondaryChange of the perceived physical self-conceptMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionThe pictorial scale of Physical Self-Concept in Children. Minimum and maximum response values are from 1 to 4. Higher scores mean a better outcome.ClinicalTrials.gov
SecondaryChange of the sedentary behaviourMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionYouth Leisure-Time Sedentary Behaviour Questionaire in minutesClinicalTrials.gov
SecondaryChange of the school satisfactionMeasured at baseline, immediately after the intervention and 8-10 weeks after the interventionIntrinsic Satisfaction Classroom Scale. Minimum and maximum response values are from 1 to 5. Higher scores mean a better outcome.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
40450427DERIVEDPubMed

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Digit Span TestPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition
Arithmetic Fluency TaskSecondary outcomeConductCognition

Source 4

FieldValueSource
Releasetrials-2026-11-12-0.3.0ClinicalTrials.gov
Release manifest SHA-2564a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.3.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.